Medacta Group reported preliminary, unaudited revenue of 683.8 million euros for full-year 2025, a year-over-year increase of 18.5% in constant currency and 15.8% in euros.
The orthopedic device company said growth was driven by strong performance across all business lines and geographic regions, with Asia Pacific revenue rising 23% and North America increasing 19%. Latin America, the smallest market, grew 42.2%, according to a Feb. 3 news release shared with Becker’s.
By product line, knee revenue rose 20.7% in constant currency to 284.1 million euros, hip grew 11.9% to 270.5 million euros, extremities increased 46.2% to 72.1 million euros and spine rose 12.2% to 57 million euros.
The March 2025 acquisition of Parcus Medical contributed about 1.5% to annual revenue. Medacta also added 258 new jobs during the year and is close to completing a new fully automated warehouse in Italy to support its supply chain in Europe, the Middle East and Africa.
The company will release audited 2025 financial results March 13.
